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Background

The products of clot degradation can prove useful in clinical situations for evaluation of
suspected thromboembolism. During one of the final stages of thrombus formation,
fibrin monomers are cross-linked by factor XIII to form a stable clot1, 2. Degradation of
these monomer chains results in characteristic by-products including D-dimers.
Elevated D-dimer levels indicate that a cross-linked clot has been formed and that it has
since been lysed by plasmin3. Therefore elevated D-dimer levels are seen in conditions
of pathologic coagulation, including deep vein thrombosis (DVT)4 and pulmonary
thromboembolism (PE).

It is important that DVT be accurately diagnosed and treated to avoid its progression to
PE, a potentially fatal condition. Diagnosis of DVT can be challenging because its
incidence is low and physical symptoms or pain, swelling and tenderness are common
and fairly non-specific. The use of objective tests is required in the evaluation of DVT.
Recently, the measurement of plasma D-dimer levels has been established as a single
laboratory test capable of excluding DVT and PE in patients who have a low “pretest”
clinical probability of thromboembolism.4

The specificity of the quantative D-dimer assays is fairly low (39-53%) because a
number of conditions, such as infection, inflammation, vasculitis, pregnancy, trauma,
hemorrhage, malignancy and recent surgery can result in elevated D-dimer levels5, 6.
Conversely, the sensitivity of the assay is 96-100% and the negative predictive value is

93-100%7, 8 in patients with a low to moderate pretest probability of DVT. A negative
test can therefore be used to exclude thromboembolism from the differential diagnosis,
eliminating the need for further testing such as compression ultrasonography. D-dimer
evaluation has also shown promise in the evaluation of suspected recurrent DVT9 and
PE6,as well as in diagnosis of acute aortic dissection10.

For normal clinical evaluation, D-dimer measurements are performed on fresh plasma.
However for research and quality assurance purposes, platelet-poor plasma is often
frozen and stored for later batch testing. The Clinical and Laboratory Standards
Institute (formerly the NCCLS) guidelines state that platelet-poor plasma samples may
be stored for up to two weeks at -20°C and up to six months at -70°C 11. The
manufacturer’s instructions for the STA®-Liatest®, a particular D-dimer assay marketed
by Diagnostica Stago (Asnieres-sur-Seine, France), indicate that plasma samples may
be stored at 20 + 5°C for up to 8 hours or for up to one month at -20°C 12.

Most research studies have employed storage of samples at -70oC4 7 or even -80 oC13
for platelet-poor plasma samples. However, adequate research is lacking to show the
stability of platelet-poor plasma during long term storage at a range of temperatures.
Previous studies have investigated stability of coagulation markers at -20oC, but these
studies have been either small or of short duration4, 14. Bates et al found stable D-dimer
levels after storage for two months at -20 °C. Woodhams et al demonstrated D-dimer
stability at -74 + 2°C as well as -24 + 2°C in a study of six normal patients.

Clear demonstration of D-dimer stability in platelet-poor plasma during storage at -20 °C
would simplify the storage of samples used for laboratory research.

Previous work on this project investigated storage of samples of platelet-poor plasma
with normal D-dimer levels at both -20 °C and -70 °C. D-dimer levels were assayed at
intervals for up to one year and no significant change in D-dimer levels were observed
over the storage period. However, this previous investigation, as well as others, has
only investigated D-dimer stability in samples with normal D-dimer levels (i.e. among
asymptomatic subjects). In the current study, we tested the hypothesis that elevated Ddimer levels, as measured in the platelet-poor plasma of symptomatic subjects, will not
change significantly over a period of 6 to 12 months, whether stored at -20 °C or -70°C.

Methods
The sample size was estimated using the Student t distribution, assuming a 2-tailed
statistical model for determination of sample size. Under these assumptions, it was
estimated that at least 37 subjects would be required. The samples were obtained
consecutively as they are identified during clinical evaluation of symptomatic patients at
UNMH. All samples were collected under the approved UNM HRRC protocol #04-230.

All blood samples were collected into sodium citrate Vacutainers™ with all personal
identifying information removed (with the exception of sex and age) prior to sample
processing. Eligible samples are defined as those with D-dimer levels >0.5 μg
(FEU)/mL, the upper normal limit used to exclude venous thromboembolism. When

such a sample was identified, technicians set aside the blood sample that would
ordinarily be discarded. The blood sample was refrigerated at 4°C until processing.
Within 8 hours of draw, the specimen was centrifuged at room temperature for at least
15 minutes at 2500 g. After being centrifuged, the platelet-poor plasma was dissociated
from any personal identifying information and separated into 250μL aliquots in six or
eight labeled Eppendorf tubes. The Eppendorf tubes were labeled with the specimen
number, sex of the patient (M/F 1, 2, 3, etc.), at what month the D-dimer level will be reevaluated (1, 3, 6 and 12 months) and the temperature in which the specimen will be
stored. The specimens were then separated and stored at either -20°C or -70°C.
Samples were initially stored at the lab at UNM Hospital, and then transferred to TriCore
Laboratories within one month where they were stored and analyzed for the duration of
the study.

All baseline values were established on the day of the draw. After storage for one,
three, six and possibly twelve months the D-dimer levels were again tested. The
specimens were thawed for three minutes at 37°C prior to the D-dimer level
measurement with the STA®-Liatest® D-dimer assay.

Data analysis:
Univariate analysis of numeric variables was carried out using standard methods. Ddimer change over time was calculated by subtracting the baseline D-dimer level from
the value measured at each time. Multivariate analysis of variance was used to assess
differences in D-dimer change over time for each storage temperature.

Calculations:
All calculations were performed on an Intel Pentium-based microcomputer with a clock
speed of 1.8 GHz. Statistical calculations were made with Statgraphics Plus for
Windows Version 4.1, Manugistics, Inc., Rockville, MD. Data management was carried
out using Microsoft Excel 2002 (Microsoft Corporation, Redmond, WA.) Two-tailed
tests and a Type I error rate of 0.05 were employed throughout.

Results
Samples from 46 patients with elevated D-dimer levels were identified and included in
this study. Subject ages varied from 17 to 83 with a mean age of 43. There were 30
females (65%) and 16 males (35%). There were 299 samples available for analysis.
There was one outlying point, which was preceded and followed by consistent D-dimer
levels. This point was considered spurious and its value was set to the mean of that
subject’s remaining D-dimer data points.

The mean D-dimer differences at each storage temperature and month of storage
ranged from -0.18 to 0.26 μg (FEU)/mL (see table 1) with an overall positive trend
during the storage time. The temperature at which the samples were stored was not
associated with a significant change in d-dimer difference (p=0.67) (see figure 1). The
d-dimer level did not change appreciably over time (p=0.68).
1

3

6

12

-20°C

0.06

0.04

0.00

0.02

-70°C

0.07

-0.18

0.26

0.23

Table 1. Mean D-dimer difference from baseline at each temperature and month. Units are μg (FEU)/mL.
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Figure 1. Difference in D-dimer levels from baseline at 1, 3, 6 and 12 months at storage temperatures of 20°C and -70°C. The units of difference are μg (FEU)/mL. Regression lines shows trend over time for
each temperature.

Discussion
This study demonstrates that D-dimer levels in platelet poor plasma from patients with
an elevated D-dimer level do not change significantly when stored at -20°C compared to
-70°C for up to 12 months. Previously published studies have analyzed plasma with
normal D-dimer levels and have been either small14 or short in duration4 and have
studied patients with normal D-dimer levels.

The trend over the 12 month storage period for the change from baseline D-dimer level
was generally positive for both -20°C and -70°C. However, at the end of 12 months, the
average change in D-dimer concentration was 0.02 for those samples stored at -20°C, a
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change which is unlikely to be clinically significant (p= 0.99). The p value for the overall
influence of temperature was 0.67. The mean change in samples stored at -70º was
0.23 after storage for 12 months. Although the magnitude of change was higher for the
samples stored at -70ºC, the p value for the influence of storage time was 0.34 for the
samples stored at -70ºC. Overall, these data indicate that platelet-poor plasma samples
can be stored at -20°C rather than -70°C without clinically or statistically significant
change.

The samples that were stored -70°C had to be moved from one freezer to another
during the course of storage due to a freezer malfunction. This could have lead to slight
thawing and refreezing of samples prior to testing; however, we believe any such
variance was minimal because technicians were alerted to the problem prior to any
significant thawing of the freezer contents. Moreover, because samples were collected
in a staggered fashion, this move would not have affected all samples stored at this
temperature.

One limitation of this study is that our protocol for processing the blood samples may be
different than is done in different institutions. The protocol we designed allowed whole
blood to be refrigerated at 4°C for up to 8 hours prior to sample processing. Protocols
elsewhere may differ from this. Additionally, our centrifugation of the samples at 2500g
for at least 15 minutes may be different from protocols elsewhere and may result in
differing platelet concentration of the plasma. Because of these differences, our
findings may not be generalizable to all platelet-poor plasma samples.
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Conclusion
Our findings demonstrate that platelet-poor plasma from patients with elevated D-dimer
levels can be stored for up to 12 months at -20°C rather than -70°C without a
statistically significant change in D-dimer concentration as measured by the STA®Liatest® D-Di.

Acknowledgements
We would like to thank Dr. Dan Tandberg for his help with the statistical analysis. We
would also like to thank the UNMH laboratory personnel for their help in identifying
suitable samples for this study. Lastly we would like to thank the TriCore Laboratory
personnel Kelly Townsend, Pam Owens and Donna Rospopo for their technical support.

References
1.
2.
3.
4.

5.
6.

Goodnight S, WE H. Disorders of Hemostasis and Thrombosis: A clinical guide.
Second ed. New York: McGraw-Hill; 2001.
McClatchey K, Hackel E. Clinical laboratory medicine. Second ed. Philadelphia:
Lippincott Williams & Wilkins; 2002.
De Loughery T. Hemostasis and Thrombosis. Austin, TX: Landes Bioscience;
1999.
Bates S, Grand'Maison A, Johnston M, Naguit I, Kovacs M, Ginsberg J. A Latex
D-Dimer Reliability Excludes Venous Thromboembolism. Arch Intern Med.
2001;161(3):447-453.
Bockenstedt P. D-Dimer in Venous Thromboembolism. N Engl J Med.
2003;349(13):1203-1204.
Brown M, Rowe B, Reeves M, Bermingham J, Goldhaber S. The accuracy of the
enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary
embolism: A meta-analysis. Ann Emerg Med. 2002;40(2):133-144.

7.

8.

9.
10.
11.

12.
13.
14.

Houbouyan-Reveillard L, Mihoubi A, Houdijk W, et al. Preliminary Evaluation of
two New Rapid Immunoturbidimetric D-dimer Assays in Patients with Clinically
Suspected Venous Thromboembolism (VTE). Thromb Haemost. 2000;84(5):770774.
Bucek R, Koca N, Reiter M, Haumer M, Zontsich T, Minar E. Algorithms for the
diagnosis of deep-vein thrombosis in patients with low clinical pretest probability.
Thromb Res. 2002;105(1):43-47.
Rathburn S, Whitsett T, Raskob G. Negative D-dimer to exclude recurrent deep
venous thrombosis: a management trial. Ann Intern Med. 2001;141:839-845.
Weber T, Hogler S, Auer J, et al. D-dimer in Acute Aortic Dissection. Chest.
2003;123(5):1375-1378.
Standards, NCCLS. Collection, Transport, and Processing of Blood Specimens
for Testing Plasma-Based Coagulation Assays; Approved Guidelines. Vol 23.
Fourth ed. Pennsylvania: NCCLS; 2003.
STA®-Liatest® D-Di [package insert]. Asnieres-sur-Seine, France: Diagnostica
Stago; 2002.
Iverson L, Thorlacius-Ussing O. Short-time stability of markers of coagulation and
fibrinolysis in frozen plasma. Thromb Res. 1996;81(2):253-261.
Woodhams B, Giradot O, Blanco M, Golesse G, Gourmelin Y. Stability of
coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis.
2001;12(4):229-236.

